• Another Humira biosimilar hits EU shores pharmatimes
    October 19, 2018
    Samsung Bioepis has announced the European launch of Humira biosimilar Imraldi, as NHS chiefs tell Trusts to ensure they are ready to realise the potential savings from using cheaper versions of the world’s biggest selling drug.
PharmaSources Customer Service